Bausch Health Companies

Bausch Health Companies

BHC· Manufacturing· Fiscal year ends in December

CEO pay in FY2025

Thomas J. Appio is the CEO of Bausch Health Companies and was paid $16.9M in FY2025 (Dec), up 4%.

PayNo stock prices for these years
CEO pay is from each Bausch Health Companies proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives4

See all
  1. 1Thomas J. AppioFY2025
  2. 2Jean-Jacques CharhonFY2025
  3. 3Seana CarsonFY2025
  4. 4Aimee J. LenarFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Bausch Health Companies paid its 4 named executives $29.3M in total in FY2025 (Dec). CEO Thomas J. Appio was paid $16.9M of that.

Name
Thomas J. AppioChief Executive Officer
Jean-Jacques CharhonExecutive Vice President, Chief Financial OfficerNot disclosed
Seana CarsonExecutive Vice President, General Counsel
Aimee J. LenarExecutive Vice President, US PharmaNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers13

See all

The FY2025 (Dec) proxy of Bausch Health Companies names 13 peer companies for pay. Pay versus performance data of Bausch Health Companies for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board1

See all
  • Richard C. MulliganDirector · 2 yr on the boardIndependentNominating and Corporate Governance, Science and Technology (Chair)—Paid as an executive

The board of the latest proxy (FY2024).

Activity

Filings6

See all
Proxy statementDEF 14AApr 8, 2026FY2025
Annual report10-KFeb 19, 2026FY2025
Proxy statementDEF 14AApr 2, 2025FY2024
Annual report10-KFeb 20, 2025FY2024
Proxy statementDEF 14AApr 4, 2024FY2023
Annual report10-KFeb 22, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data